206 related articles for article (PubMed ID: 8712118)
1. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
[TBL] [Abstract][Full Text] [Related]
2. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC
Am J Cardiol; 1997 Feb; 79(4):431-5. PubMed ID: 9052345
[TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
Applegate W; Cohen JD; Wolfson P; Davis A; Green S
Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
[TBL] [Abstract][Full Text] [Related]
4. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
5. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension.
Cushman WC; Cohen JD; Jones RP; Marbury TC; Rhoades RB; Smith LK
Am J Hypertens; 1998 Jan; 11(1 Pt 1):23-30. PubMed ID: 9504446
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group.
Elliott WJ; Montoro R; Smith D; Leibowitz M; Hwang C; Gradman AH; Schleman M; Klibaner M
Am J Hypertens; 1999 Jul; 12(7):691-6. PubMed ID: 10411366
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension Group.
Chrysant SG; Gavras H; Niederman AL; Marbury TC; Goldstein R
J Clin Pharmacol; 1997 Sep; 37(9):810-5. PubMed ID: 9549634
[TBL] [Abstract][Full Text] [Related]
9. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group.
Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC; Michelson EL
Clin Ther; 1998; 20(3):527-38. PubMed ID: 9663368
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group.
Ruddy TD; Wright JM; Savard D; Handa SP; Chockalingam A; Boulet AP
Cardiovasc Drugs Ther; 1995 Jun; 9(3):413-20. PubMed ID: 8527351
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.
Sierra A; Roca-Cusachs A; Redón J; Marín R; Luque M; Figuera M; Garcia-Garcia M; Falkon L
Clin Drug Investig; 2009; 29(7):459-469. PubMed ID: 19499963
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
19. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
Byyny RL; Merrill DD; Bradstreet TE; Sweet CS
Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
Küppers HE; Jäger BA; Luszick JH; Gräve MA; Hughes PR; Kaan EC
J Hypertens; 1997 Jan; 15(1):93-7. PubMed ID: 9050976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
